Results 51 to 60 of about 3,685 (179)

Image_2_Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis.jpg

open access: yes, 2022
ObjectiveTo date, the influence of the carboxylesterase 1 (CES1) rs2244613 genotype on the pharmacokinetics (PKs) and safety of dabigatran remains controversial.
Xianbo Zuo (410580)   +11 more
core   +1 more source

Safety of dabigatran in patients with atrial fibrillation and chronic kidney disease: pharmacokinetic and pharmacogenetic aspects

open access: yesМедицинский совет, 2020
Background: despite well-studied safety profile of dabigatran its interactions with genetic polymorphism parameters are poorly understood, especially in patients with moderate chronic kidney disease (CKD).
A. I. Skripka   +12 more
doaj   +1 more source

Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus [PDF]

open access: yesPharmacogenetics and Genomics, 2016
CES1 encodes carboxylesterase-1, an important drug-metabolizing enzyme with high expression in the liver. Previous studies have reported a genomic translocation of the 5' region from the poorly expressed pseudogene CES1P1, to CES1, yielding the structural variant CES1VAR.
Jonathan C, Sanford   +6 more
openaire   +2 more sources

Association between CES1 mRNA expression level in adipose tissue and measures of glucose and lipid metabolism.

open access: yes, 2013
The statistical model is: ln(response variable) = age+sex+BMI+CES1 mRNA level. The regression coefficient expresses the change in the response variable associated with a doubling of CES1 mRNA level from its average. CES1: carboxylesterase 1 gene; HOMA-IR:
Peter Riis Hansen (283251)   +5 more
core   +1 more source

Image_1_Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis.jpg

open access: yes, 2022
ObjectiveTo date, the influence of the carboxylesterase 1 (CES1) rs2244613 genotype on the pharmacokinetics (PKs) and safety of dabigatran remains controversial.
Xianbo Zuo (410580)   +11 more
core   +1 more source

Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump

open access: yesJournal of Lipid Research, 2012
Z-Guggulsterone is a major ingredient in the Indian traditional hypolipidemic remedy guggul. A study in mice has established that its hypolipidemic effect involves the farnesoid X receptor (FXR), presumably by acting as an antagonist of this receptor. It
Dongfang Yang   +7 more
doaj   +1 more source

Table_1_Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis.docx

open access: yes, 2022
ObjectiveTo date, the influence of the carboxylesterase 1 (CES1) rs2244613 genotype on the pharmacokinetics (PKs) and safety of dabigatran remains controversial.
Xianbo Zuo (410580)   +11 more
core   +1 more source

Effect of selected variables on CES1 mRNA expression level in adipose tissue.

open access: yes, 2013
The statistical model is: ln(CES1 mRNA level) = age+gender+BMI. The regression coefficient expresses the change in the response variable associated with an increase of one unit in an explanatory variable.
Peter Riis Hansen (283251)   +5 more
core   +1 more source

A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease

open access: yesCells, 2022
Background: Myeloid cells are critical determinants of the sustained inflammation in Crohn’s Disease (CD). Targeting such cells may be an effective therapeutic approach for refractory CD patients. Bromodomain and extra-terminal domain protein inhibitors (
Ahmed M. I. Elfiky   +17 more
doaj   +1 more source

Horse carboxylesterases: Evidence for six CES1 and four families of CES genes on chromosome 3

open access: yes, 2009
Carboxylesterases (CES) are responsible for the detoxification of a wide range of drugs and xenobiotics, and may contribute to cholesterol, fatty acid and lung surfactant metabolism.
A. Cox, Laura   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy